ARCHIVES

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

This article is from The Cancer Letter archive.

Vol. 22 No. 03 | January 19, 1996

Download PDF Visit The Full Archive

Related Articles

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Loehrer To Direct IU Simon Cancer Center

March 5, 2010

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

Other DCT Concepts Approved By BSC

June 6, 1986

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010